EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY-NC-ND 4.0

Pharmacokinetic Comparison Between a Fixed‐Dose Combination of Atorvastatin/Fenofibrate 20/145 mg and the Corresponding Individual Components

Seungri Lee, Juyoung Khwarg, Sungyeun Bae, Dong-Min Park, Heejung Park, SeungHwan Lee, Kyung-Sang Yu

Clinical Pharmacology in Drug Development · 2026-03 · 15 (3)

DOI: 10.1002/cpdd.70043 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Pharmacology in Drug Development, online erschienen am 10.03.2026. Verfasst von Seungri Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Atorvastatin, Fenofibrate, Hypolipidemic Agents, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Co‐administration of atorvastatin and fenofibrate has demonstrated clinical benefits in patients with dyslipidemia. To improve convenience and adherence, a fixed‐dose combination (FDC) of the two agents has gained interest. This study aimed to compare the pharmacokinetics (PKs) and safety of an FDC of atorvastatin/fenofibrate 20/145 mg with the corresponding individual components. A randomized, open‐label, single‐dose, two‐sequence, two‐treatment, four‐period full replicated crossover study was conducted. Participants were randomly assigned to one of the two sequences and received FDC or individual components. PK parameters were estimated using a non‐compartmental method. The geometric mean ratio (GMR) and its 90% confidence interval (CI) of the FDC to the individual components were calculated using mixed effect model. A total of 36 participants completed the study. The GMRs (90% CIs) for maximum plasma concentration and area under the time‐concentration curve from zero to the last measurable point were 1.1038 (0.9985‐1.2202) and 1.0148 (0.9745–1.0567) for atorvastatin, 1.0032 (0.9261‐1.0867) and 0.9882 (0.9520–1.0258) for 2‐OH atorvastatin. For fenofibric acid, the corresponding values were 0.9896 (0.8810‐1.1116) and 0.9871 (0.8869‐1.0986), respectively. The FDC of atorvastatin/fenofibrate 20/145 mg showed comparable PK profiles to the corresponding individual components, supporting its potential as an alternative therapeutic option for dyslipidemia with convenience.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtorvastatinFenofibrateHypolipidemic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHumansMaleCross-Over StudiesFemaleAdultDrug CombinationsMiddle AgedArea Under CurveYoung AdultDyslipidemias

Stichwörter der Autor:innen

atorvastatincomparative pharmacokinetic studydyslipidemiafenofibratefixed‐dose combination

Substanzen

AtorvastatinFenofibrateDrug CombinationsHypolipidemic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
  • Yuhan R&D Institute, Yuhan Corporation, Yongin-si, Gyeonggi-do, Republic of Korea.

Zitieren

APA

Lee, S., Khwarg, J., Bae, S., Park, D. M., Park, H., Lee, S., & Yu, K. S. (2026). Pharmacokinetic Comparison Between a Fixed‐Dose Combination of Atorvastatin/Fenofibrate 20/145 mg and the Corresponding Individual Components. Clinical Pharmacology in Drug Development, 15(3). https://doi.org/10.1002/cpdd.70043

Vancouver

Lee S, Khwarg J, Bae S, Park DM, Park H, Lee S, et al. Pharmacokinetic Comparison Between a Fixed‐Dose Combination of Atorvastatin/Fenofibrate 20/145 mg and the Corresponding Individual Components. Clinical Pharmacology in Drug Development. 2026;15(3). doi:10.1002/cpdd.70043

BibTeX
@article{Lee2026,
  author = {Lee, Seungri and Khwarg, Juyoung and Bae, Sungyeun and Park, Dong-Min and Park, Heejung and Lee, SeungHwan and Yu, Kyung-Sang},
  title = {Pharmacokinetic Comparison Between a Fixed‐Dose Combination of Atorvastatin/Fenofibrate 20/145 mg and the Corresponding Individual Components},
  journal = {Clinical Pharmacology in Drug Development},
  year = {2026},
  volume = {15},
  number = {3},
  doi = {10.1002/cpdd.70043}
}
Kostenlos starten →